Community Academic Profiles

Gregory W. Albers

Publication Details

  • Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.

    White HD, Gruber M, Feyzi J, Kaatz S, Tse HF, Husted S, Albers GW. Arch Intern Med. 2007; 167 (3): 239-45

    Warfarin sodium reduces stroke risk in patients with atrial fibrillation, but international normalized ratio (INR) monitoring is required. Target INRs are frequently not achieved, and the risk of death, bleeding, myocardial infarction (MI), and stroke or systemic embolism event (SEE) may be related to INR control.

    PubMedID: 17296878

Stanford Medicine Resources:

Footer Links: